The head of the US effort to produce a coronavirus vaccine has said, the first immunisation could happen on December 12.
A Food and Drug Administration advisory committee is set to meet on December 10 to discuss Pfizer Inc.’s request for an emergency use authorisation for its developing Covid-19 vaccine.
US drug maker Pfizer Inc, has claimed that they developed a 95% effective vaccine against coronavirus. They are now seeking the emergency use tag from US government for its dosage. Pfizer has said the emergency use tag could start the process early and the coronavirus vaccine doses could be available as early as next month.
Dr. Moncef Slaoui, head of Operation Warp Speed, the coronvirus vaccine program said that their plan is able to ship vaccines to the immunisation sites within 24 hours from the approval.
Meanwhile leaders of the 20 biggest economies vowed to spare no effort to supply Covid-19drugs, tests and vaccines affordably and fairly to ‘all people”, reflecting worries that the pandemic could deepen divisions between the world’s rich and poor.
Meanwhile Niti Ayog member and National Expert Group on Vaccine Administration for COVID-19, Vinod Paul said that Pune-based Serum Institute (SII) may be granted emergency use authorisation of the Oxford AstraZeneca coronavirus vaccine if AstraZeneca get approval from the UK government. He also said that if the clinical trials of the coronavirus vaccine in India go as per the script, phase III trials should be over by January-February 2021.
